<DOC>
	<DOCNO>NCT01108380</DOCNO>
	<brief_summary>For patient liver cirrhosis need right extend right hepatectomy , treat autologous peripheral stem cell transplantation facilitate liver regeneration . We asses liver regeneration evaluation liver volume liver function test .</brief_summary>
	<brief_title>Evaluation Liver Regeneration With Autologous Peripheral Stem Cells</brief_title>
	<detailed_description>1 . Patients : 30 patient ( 10 patient 3 group ) 2 . Indication : - Patients Primary hepatocellular carcinoma combine liver cirrhosis ( Hepatitis B , C , Non-B Non-C ) - Planned right hepatectomy extend right hepatectomy - Patients need right portal vein embolization due insufficient expect remnant liver volume ( &lt; 40 % ) severe hepatic dysfunction ( ICGR15 &gt; 10 % ) - Child A classification - ICG R15 &lt; 25 % - Age : 20 - 70 year old - Expected life period &gt; 3months - The patient agree study . 3 . Contraindication - Patients plan liver transplantation - Age &lt; 20 &gt; 70 year old - Pregnant woman - Patients acute infection - Acute hepatic failure - Child class B C - Heart failure - Existence bleeding tendency : platelet &lt; 30,000 , INR &gt; 2.2 , Cr &gt; 2.5 - Patients agree study . 4 . Allocation : We allocate patient randomly three group include control group . 5 . Methods - Group 1 : 4 day injection G-CSF - &gt; Plasma pheresis , Selection CD34 cell - &gt; Right portal vein embolization infusion CD34 cell leave portal vein . - Group 2 : 4 day injection G-CSF - &gt; Plasma pheresis - &gt; Right portal vein embolization infusion mononuclear cell leave portal vein . - Group 3 ( control ) : Right portal vein embolization ( - &gt; 4 week , operation perform ) 6 . Evaluation : Change liver volume , liver function test portal vein embolization</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<criteria>1 . Patients Primary hepatocellular carcinoma combine liver cirrhosis ( Hepatitis B , C , NonB NonC ) 2 . Planned right hepatectomy extend right hepatectomy 3 . Patients need right portal vein embolization due unsufficient expect remnant liver volume ( &lt; 40 % ) severe hepatic dysfunction ( ICG R15 &gt; 10 % ) 4 . Child A classification 5 . ICG R15 &lt; 25 % 6 . Age : 20 70 year old 7 . Expected life period &gt; 3months 8 . The patient agree study 1 . Patients plan liver transplantation 2 . Age &lt; 20 &gt; 70 year old 3 . Pregnant woman 4 . Patients acute infection 5 . Acute hepatic failure 6 . Child class B C 7 . Heart failure 8 . Existence bleed tendency : platelet &lt; 30,000 , INR &gt; 2.2 , Cr &gt; 2.5 9 . Patients agree study</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>Liver cirrhosis</keyword>
	<keyword>liver regeneration</keyword>
	<keyword>liver volume</keyword>
	<keyword>liver function</keyword>
	<keyword>hepatocellular carcinoma , extensive</keyword>
	<keyword>hepatectomy</keyword>
</DOC>